STATEMENT OF IDENTITY
Dietary Supplement
Dietary Supplement
Take two (2) capsules daily, after meal(s), or as directed by your healthcare provider. Do not exceed two (2) capsules daily.
If reaction(s) occur, consult your physician. Consult your doctor before starting any dietary supplement regime. This product is a dietary supplement, not a prescription drug. Keep out of the reach of children. In case of accidental overdose, call a hospital or poison control center immediately. Do not use if safety seal is damaged or missing. Do not expose to excessive heat or moisture. Store at room temperature in a cool dry place. Keep out of sunlight.
| Class | Version | Type | Effective |
|---|---|---|---|
| ACETYLCYSTEINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| LEVOCARNITINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 7b19f89e-0a13-4d4e-a994-a46d39d008b9 | Product name | 1 | 20251120 |
| 08c722ec-780f-bb7b-8f14-3d4f7bf0e098 | Product name | 2 | 20240205 |
| 13c3e0af-2da2-8aec-9e17-1afd680d80c2 | Product name | 8 | 20221116 |
| e2f276e5-439f-b432-b5e5-b0cfa993da69 | Product name | 3 | 20220609 |
| 91c62db0-0295-c81c-d10a-0856c259edd6 | Product name | 2 | 20200428 |
| d32bc2b8-0bb7-2216-87aa-24639646e202 | Product name | 3 | 20190619 |
| f46c867f-cde5-4f14-a7c1-18ae3a6efd1c | Product name | 1 | 20160303 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| 4585a4fb-0028-3d95-020c-9b1c40bf15e0 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73489-006-01 | ULTRA PCOS CITRUS | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 2 | |
| 73489-006-02 | ULTRA PCOS CITRUS | 60 in 1 BOTTLE, PLASTIC | CAPSULE | 60 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 73489-006 | ULTRA PCOS CITRUS (ACETYLCYSTEINE, GAMOLENIC ACID, GYMNEMA SYLVESTRE LEAF, INOSITOL, CHINESE CINNAMON, ARGININE HYDROCHLORIDE, LEVOCARNITINE TARTRATE, UBIDECARENONE, THIOCTIC ACID, ALTHAEA OFFICINALIS ROOT, GLUTATHIONE, CHIRO-INOSITOL, LAGERSTROEMIA SPECIOSA WHOLE) CAPSULE [CROWN GENERAL AGENCY INC] | 2 | 2 package rows | 20211023_ea4c673b-e4f2-4fdc-bb1e-07ac0df0b436.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 73489-006-01 | EA - Each | 73489-006 | e0d95c94-169c-46ea-af65-37d6cee112f0 | 1 | 2021-01-08 |
| 73489-006-02 | EA - Each | 73489-006 | 2a3f142c-b51b-404c-9f1d-a28497f32523 | 1 | 2021-01-08 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73489-006 | 73489-006-01, 73489-006-02 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetylcysteine | ACETYLCYSTEINE | Hospira, Inc. | 5558a5f5-e821-473b-7d8a-5d33d09f0586 | 2026-05-22 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Glenmark Pharmaceuticals Inc., USA | f811ddfc-d7c1-4637-ae81-80c38a77cb80 | 2026-05-06 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Somerset Therapeutics, LLC | d50c8ab6-26f8-4669-89d1-c4d26698159a | 2026-04-11 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Cardinal Health 107, LLC | c90fca12-12fb-4cf6-bd6f-83bc0d95df81 | 2026-04-07 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Eugia US LLC | 5ae53725-1abb-4122-9c85-f26c2c31566c | 2025-12-02 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Sagent Pharmaceuticals | c206c659-16ea-444a-8c60-8a3343400ada | 2025-10-26 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | ONESOURCE SPECIALTY PHARMA LIMITED | 3b0310d2-4e70-4b94-8d69-cb5999a32b54 | 2025-09-12 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Hikma Pharmaceuticals USA Inc. | 277963a0-8ab2-4305-a688-28e47e87c584 | 2025-09-09 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Cameron Pharmaceuticals | 8165ad85-98e7-438f-9567-5cfda88d0ebf | 2025-08-26 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| acetylcysteine | ACETYLCYSTEINE | Padagis US LLC | 9d305722-e74f-4f48-8d2c-0daa99144749 | 2025-07-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| ACETADOTE | ACETYLCYSTEINE | Cumberland Pharmaceuticals Inc. | 472f158a-5ab9-4308-8e49-1116e6ea3d39 | 2025-04-30 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | American Regent, Inc. | f56b4087-db48-4fd7-84ec-9c927962b805 | 2024-12-17 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 75b48fab-cef6-465c-a1e0-d085b3988bc4 | 2024-08-15 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Somerset Therapeutics, LLC | b8d3ed96-d7ee-43f4-986c-a7d04808711a | 2024-06-13 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Xellia Pharmaceuticals USA LLC | 3e2e187e-2445-43b1-b66c-b828e2adf022 | 2023-05-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 8cca4e4c-85a2-d575-e053-2995a90a6599 | 2022-10-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | d990ef51-ced2-4359-b99b-092334d2dc9b | 2022-10-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 8d81039e-20ef-5144-e053-2a95a90a89fd | 2022-10-31 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| Acetylcysteine | ACETYLCYSTEINE | Sagent Pharmaceuticals | 2324d60b-4f49-4759-a46e-a06bfce7e8aa | 2022-04-05 | Warnings, Adverse reactions | ACETYLCYSTEINE |
| ACETYLCYSTEINE | ACETYLCYSTEINE | Indoco Remedies Limited | 6588c28d-0515-4cdf-99d3-c4ad3fd0976c | 2022-03-01 | Warnings, Adverse reactions | ACETYLCYSTEINE |
Adverse event summaries are temporarily unavailable. Other product information remains available.